Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.700 USD | -0.51% |
|
-3.48% | +3.97% |
02-10 | CVS Health Fiscal 2025 EPS Outlook Seen Lower on Health Care Benefits Segment, UBS Says | MT |
02-07 | Walgreens Boots Alliance Cuts Stake in Cencora to About 6% | MT |
Projected Income Statement: Walgreens Boots Alliance, Inc.
Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 139,537 | 132,509 | 132,703 | 139,081 | 147,658 | 151,894 | 154,826 | 157,499 |
Change | - | -5.04% | 0.15% | 4.81% | 6.17% | 2.87% | 1.93% | 1.73% |
EBITDA 1 | 7,138 | 6,567 | 6,268 | 5,002 | 4,008 | 3,298 | 3,224 | 3,607 |
Change | - | -8% | -4.55% | -20.2% | -19.87% | -17.7% | -2.26% | 11.87% |
EBIT 1 | 5,211 | 5,117 | 5,133 | 3,871 | 2,624 | 1,799 | 1,777 | 2,034 |
Change | - | -1.8% | 0.31% | -24.59% | -32.21% | -31.43% | -1.21% | 14.46% |
Interest Paid 1 | -639 | -905 | -400 | -580 | -482 | -567.7 | -556.6 | -652.2 |
Earnings before Tax (EBT) 1 | 743 | 1,995 | 3,985 | -5,419 | -14,219 | -1,358 | -720.5 | 200.7 |
Change | - | 168.51% | 99.75% | - | 162.39% | 90.45% | 46.95% | - |
Net income 1 | 456 | 2,542 | 4,337 | -3,080 | -8,636 | -678.6 | -484.7 | 323.5 |
Change | - | 457.46% | 70.61% | - | 180.39% | 92.14% | 28.57% | - |
Announcement Date | 10/15/20 | 10/14/21 | 10/13/22 | 10/12/23 | 10/15/24 | - | - | - |
Forecast Balance Sheet: Walgreens Boots Alliance, Inc.
Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 15,722 | 7,787 | 9,202 | 8,323 | 6,440 | 7,103 | 6,919 | 5,999 |
Change | - | -50.47% | 18.17% | -9.55% | -22.62% | 10.3% | -2.59% | -13.3% |
Announcement Date | 10/15/20 | 10/14/21 | 10/13/22 | 10/12/23 | 10/15/24 | - | - | - |
Cash Flow Forecast: Walgreens Boots Alliance, Inc.
Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 1,374 | 1,379 | 1,734 | 2,117 | 1,381 | 1,218 | 1,162 | 1,162 |
Change | - | 0.36% | 25.74% | 22.09% | -34.77% | -11.77% | -4.64% | 0.02% |
Free Cash Flow (FCF) 1 | 4,111 | 4,176 | 2,165 | 141 | -363 | -298.2 | 226 | 1,039 |
Change | - | 1.58% | -48.16% | -93.49% | -357.45% | -17.84% | -175.8% | 359.59% |
Announcement Date | 10/15/20 | 10/14/21 | 10/13/22 | 10/12/23 | 10/15/24 | - | - | - |
Forecast Financial Ratios: Walgreens Boots Alliance, Inc.
Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 5.12% | 4.96% | 4.72% | 3.6% | 2.71% | 2.17% | 2.08% | 2.29% |
EBIT Margin (%) | 3.73% | 3.86% | 3.87% | 2.78% | 1.78% | 1.18% | 1.15% | 1.29% |
EBT Margin (%) | 0.53% | 1.51% | 3% | -3.9% | -9.63% | -0.89% | -0.47% | 0.13% |
Net margin (%) | 0.33% | 1.92% | 3.27% | -2.21% | -5.85% | -0.45% | -0.31% | 0.21% |
FCF margin (%) | 2.95% | 3.15% | 1.63% | 0.1% | -0.25% | -0.2% | 0.15% | 0.66% |
FCF / Net Income (%) | 901.54% | 164.28% | 49.92% | -4.58% | 4.2% | 43.95% | -46.64% | 321.17% |
Profitability | ||||||||
ROA | 0.59% | 5.46% | 5.06% | 3.68% | -9.72% | -1.62% | -0.21% | 0.49% |
ROE | 18.91% | 20.45% | 16.39% | 11.92% | 12.35% | 13.06% | 14.28% | 16.34% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 2.2x | 1.19x | 1.47x | 1.66x | 1.61x | 2.15x | 2.15x | 1.66x |
Debt / Free cash flow | 3.82x | 1.86x | 4.25x | 59.03x | -17.74x | -23.82x | 30.61x | 5.77x |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 0.98% | 1.04% | 1.31% | 1.52% | 0.94% | 0.8% | 0.75% | 0.74% |
CAPEX / EBITDA (%) | 19.25% | 21% | 27.66% | 42.32% | 34.46% | 36.94% | 36.04% | 32.22% |
CAPEX / FCF (%) | 33.42% | 33.02% | 80.09% | 1,501.42% | -380.44% | -408.58% | 514.01% | 111.87% |
Items per share | ||||||||
Cash flow per share 1 | 6.23 | 6.412 | 4.503 | 2.616 | 1.18 | 1.882 | 2.488 | 3.132 |
Change | - | 2.92% | -29.77% | -41.91% | -54.91% | 59.56% | 32.18% | 25.91% |
Dividend per Share 1 | 1.87 | 1.88 | 1.912 | 1.92 | 1.23 | 0.8 | 1 | 1 |
Change | - | 0.53% | 1.73% | 0.39% | -35.94% | -34.96% | 25% | 0% |
Book Value Per Share 1 | 23.84 | 27.53 | 33.96 | 32.81 | 13.91 | 11.37 | 10.69 | 11.05 |
Change | - | 15.46% | 23.38% | -3.39% | -57.61% | -18.22% | -6.05% | 3.42% |
EPS 1 | 0.52 | 2.93 | 5.01 | -3.57 | -10.01 | -0.5794 | -0.2668 | 0.3873 |
Change | - | 463.46% | 70.99% | -171.26% | 180.39% | -94.21% | -53.95% | -245.18% |
Nbr of stocks (in thousands) | 866,534 | 864,987 | 864,257 | 863,261 | 863,275 | 864,153 | 864,153 | 864,153 |
Announcement Date | 10/15/20 | 10/14/21 | 10/13/22 | 10/12/23 | 10/15/24 | - | - | - |
2025 * | 2026 * | |
---|---|---|
P/E ratio | -16.7x | -36.4x |
PBR | 0.85x | 0.91x |
EV / Sales | 0.1x | 0.1x |
Yield | 8.25% | 10.3% |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WBA Stock
- Financials Walgreens Boots Alliance, Inc.

MarketScreener is also available in this country: United States.
Switch edition